{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie7itb2zjpddqki26krmdxgoz4q7znynuflmruskxp7siscfty45a",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmgongfmwrm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiajyzwqwbn4foqydui5u77akb4dela5sn3sxa5dclo6habrdal4uy"
    },
    "mimeType": "image/jpeg",
    "size": 516555
  },
  "path": "/news/2026-05-avenue-glp-weight-loss.html",
  "publishedAt": "2026-05-22T05:00:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 receptor agonists trigger within neurons, which have been largely unexplored until now. A study in mice identified key intracellular signaling processes that are tied to the weight-loss effects of the GLP-1 drug semaglutide. The work has been published in Nature Metabolism",
  "title": "Researchers identify avenue for enhanced GLP-1-induced weight loss"
}